Format

Send to

Choose Destination
Aging Male. 2018 Jul 31:1-10. doi: 10.1080/13685538.2018.1487932. [Epub ahead of print]

Hypogonadism and its treatment following ischaemic stroke in men with type 2 diabetes mellitus.

Author information

1
a Ucebnyj centr innovacionnyh medicinskih tehnologij RNIMU imeni N I Pirogova , Moskva , Russian Federation.

Abstract

Premature mortality in Russia is a major socio-economic problem, especially from acute cerebrovascular diseases which constitute 21.4% of the total mortality and is a considerable contributor to chronic disability. Risk of vascular catastrophe is higher in males than females, thought, in part, due to anti-atherosclerotic effects of oestrogens in females whilst an associated age-related deficiency of testosterone is observed in men. Clinical symptoms such as high blood pressure, changes in lipid profile, insulin resistance, obesity, and blood coagulation factors often accompany declining testosterone in males and reduced total testosterone is considered a cardiovascular risk factor. In the present study, the prevalence of hypogonadism in men who had suffered ischaemic stroke was evaluated along with the efficacy of testosterone undecanoate injections (TU) in patients with testosterone deficiency and type-2 diabetes (T2DM) in the acute phase of hemispheric ischaemic stroke. Hypogonadism was present in 66.3% of patients with ischaemic stroke, 50% with T2DM, and 26.3% without T2DM, respectively. TU treatment, at both the 2 and 5-year observation points, demonstrated significant improvements in biochemical, physical, and mental parameters. This supports that testosterone deficiency is a contributing factor in ischaemic events and that long-term testosterone therapy could play an important role in patient recovery.

KEYWORDS:

Hypogonadism; stroke; testosterone; type-2 diabetes

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center